Analysis of Implementation of the Chronic Disease Management Program (PROLANIS) Diabetes Mellitus Type 2 (DMT2) during the Covid-19 Pandemic at the West Lombok District Health Center
DOI:
https://doi.org/10.33394/j-ps.v10i2.4911Keywords:
Chronic Disease Management Program, BPJS Kesehatan, Diabetes Militus Type 2, Covid-19Abstract
The Chronic Disease Management Program (PROLANIS) is implemented by Health Social Security Administering Agency (BPJS Kesehatan) in an integrated manner involving participants, health facilities, and BPJS Kesehatan in order to maintain the health of participants with chronic diseases, especially Diabetes Militus Type 2 (DMT2). It is aimed at sufferers to achieve a better quality of life. The cost of effective and efficient health services is an important factor, because it is one of the performance-based capitation indicators in Community Health Centers (Puskesmas). Based on data from the West Lombok Health Office, West Nusa Tenggara province - Indonesia, from the top 10 most diseases, diabetes mellitus ranks 8 (eight), where in 2019 there were 8.882 cases, while in 2020 there were 9.683. The purpose of this study is to analyze the input, process and output factors of the PROLANIS program at the Puskesmas. This study is a descriptive study with qualitative and quantitative approaches, where primary data was obtained from in-depth interviews and secondary data from the Pcare Puskesmas application. The results showed that the input of PROLANIS registered participants was still very low (about 14% of the total number of participants diagnosed with DM), the process indicator of the number of PROLANIS participants who visited the puskesmas was quite high (82%), and the output indicator showed the number or ratio of participants whose blood sugar was controlled, is still very low (26%). Finally, in general, our findings are that the implementation of PROLANIS at the West Lombok District Health Center during the Covid-19 Pandemic is still not optimal in terms of input, process, and output.References
Alkaff, F. F., Illavi, F., Salamah, S., Setiyawati, W., Ramadhani, R., Purwantini, E., & Tahapary, D. L. (2021). The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting. Journal of Primary Care & Community Health, 12, 2150132720984409. https://doi.org/10.1177/2150132720984409
American Diabetes Association. (2019). Introduction: Standards of Medical Care in Diabetes—2019. Diabetes Care, 42(Supplement_1), S1–S2. https://doi.org/10.2337/dc19-Sint01
Ancong, F. P. A. (2021). Evaluasi Pelaksanaan Program Pengelolaan Penyakit Kronis (Prolanis) pada masa Pandemi Covid-19 di Puskesmas Kota Parepare [Universitas Hasanuddin]. http://repository.unhas.ac.id/id/eprint/6778/
Borek, A. J., Abraham, C., Greaves, C. J., Gillison, F., Tarrant, M., Morgan-Trimmer, S., McCabe, R., & Smith, J. R. (2019). Identifying change processes in group-based health behaviour-change interventions: Development of the mechanisms of action in group-based interventions (MAGI) framework. Health Psychology Review, 13(3), 227–247. https://doi.org/10.1080/17437199.2019.1625282
BPJS Kesehatan. (2019). Peraturan BPJS Kesehatan Nomor 2 Tahun 2019 Tentang Pelaksanaan Skrining Riwayat Kesehatan dan Pelayanan Penapisan atau Skrininf Kesehatan Tertentu serta Peningkatan Kesehatan bagi Peserta Penderita Penyakit Kronis Dalam Program Jaminan Kesehatan. https://bpjs-kesehatan.go.id/bpjs/arsip/detail/1357
Brahmantya et al. (2021). Intensitas Aktivitas Fisik Berpengaruh Terhadap Kadar Glukosa Darah Sewaktu Pasien Prolanis Diabetes Militus Tipe 2. Jurnal Medika Udayana, 10(2), 68–73.
Forouhi, N. G., & Wareham, N. J. (2014). Epidemiology of diabetes. Medicine, 42(12), 698–702. https://doi.org/10.1016/j.mpmed.2014.09.007
Kristianto, F. C., Sari, D. L., & Kirtishanti, A. (2021). Pengaruh Program Penanggulangan Penyakit Kronis (PROLANIS) terhadap Kadar Gula Darah Pasien Diabetes Melitus Tipe 2. CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal, 2(1), 8–14. https://doi.org/10.37148/comphijournal.v2i1.36
Liu, M., Yuan, X., Ouyang, J., Chaisson, J., Bergeron, T., Cantrell, D., Washington, V., Zhang, Y., & Nigam, S. (2020). Evaluation of four disease management programs: Evidence from blue cross blue shield of Louisiana. Journal of Medical Economics, 23(6), 557–565. https://doi.org/10.1080/13696998.2020.1722677
Manullang, H. J., Dachi, R. A., Sitorus, M. E. J., Priajaya, S., & Sirait, A. (2021). Analisis Implementasi Program Pengelolaan Penyakit Kronis (PROLANIS) di Puskesmas Parsoburan Kota Pematangsiantar Tahun 2021. Journal of Healthcare Technology and Medicine, 7(2), 868–890. https://doi.org/10.33143/jhtm.v7i2.1663
Meiriana, A., Trisnantoro, L., & Padmawati, R. S. (2019). Implementasi Program Pengelolaan Penyakit Kronis (PROLANIS) pada Penyakit Hipertensi di Puskesmas Jetis Kota Yogyakarta. Jurnal Kebijakan Kesehatan Indonesia : JKKI, 8(2), 51–58.
Nissinen, A., Berrios, X., & Puska, P. (2001). Community-based noncommunicable disease interventions: Lessons from developed countries for developing ones. Bulletin of the World Health Organization, 79(10), 963–970.
Nurdianto, A. R., Anhar, C. A., Anwari, F., Charisma, A. M., & Farida, E. A. (2021). Edukasi Pola Hidup Sehat dalam Mengontrol Kadar Glukosa Darah Puasa bagi Anggota Prolanis Puskesmas Trosobo, Sidoarjo saat Pandemi COVID – 19. Prosiding Seminar Nasional Pengabdian Masyarakat Universitas Ma Chung, 1, 387–399. https://doi.org/10.33479/senampengmas.2021.1.1.387-399
Soewondo, P., Ferrario, A., & Tahapary, D. (2013). Challenges in diabetes management in Indonesia: A literature review. Globalization and Health, 9(1), 63. https://doi.org/10.1186/1744-8603-9-63
Wardani, A. E., Darmawansyah, D., Russeng, S. S., Indar, I., Sukri, S., & Asdar, M. (2020). Implementation of Chronic Disease Management Program in Tajuncu Puskesmas Soppeng Regency. International Journal of Multicultural and Multireligious Understanding, 7(6), 453–463. https://doi.org/10.18415/ijmmu.v7i6.1786
Watuseke, H., Ake, J., & Akay, T. (2017). Efektivitas Senam Prolanis terhadap Penurunan Kadar Gula Darah Pasien Diabetes Melitus Tipe 2 di Praktek Klinik Dr. Fransiskus Karamoy Desa Winebetan Kecamatan Langowan Selatan. E-Jurnal UNSRIT, 4(1), Article 1. http://jurnal.unsrittomohon.ac.id/index.php?journal=ejurnal&page=article&op=view&path%5B%5D=264
World Health Organization. (2016). Global report on diabetes. https://www.who.int/publications-detail-redirect/9789241565257
World Health Organization. (2020). Diabetes. https://www.who.int/westernpacific/health-topics/diabetes
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution 4.0 International License.
